Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-VLDLR Antibody (3U184) (Synonyms: VLDLRCH, very low density lipoprotein receptor, CHRMQ1, CARMQ1, CAMRQ...)
Catalog No. TMAY-01596 Copy Product Info
🥰Excellent
Anti-VLDLR Antibody (3U184) is a Mouse antibody targeting VLDLR. Anti-VLDLR Antibody (3U184) can be used in ELISA.
Anti-VLDLR Antibody (3U184)
Copy Product Info🥰Excellent
Catalog No. TMAY-01596
Synonyms VLDLRCH, very low density lipoprotein receptor, CHRMQ1, CARMQ1, CAMRQ1
Anti-VLDLR Antibody (3U184) is a Mouse antibody targeting VLDLR. Anti-VLDLR Antibody (3U184) can be used in ELISA.
Anti-VLDLR Antibody
(3U184)
(3U184)
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 100 μL | $199 | 7-10 days | 7-10 days |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Stability & Storage
| Description | Anti-VLDLR Antibody (3U184) is a Mouse antibody targeting VLDLR. Anti-VLDLR Antibody (3U184) can be used in ELISA. |
| Synonyms | VLDLRCH, very low density lipoprotein receptor, CHRMQ1, CARMQ1, CAMRQ1 |
| Ig Type | Mouse IgG1 |
| Clone | 3U184 |
| Reactivity | Human |
| Specificity | Human VLDL Receptor/VLDLR No cross-reactivity in ELISA with Human cell lysate (293 cell line) |
| Application | |
| Recommended Dose | ELISA: 1:1000-1:2000 |
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Construction | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human VLDLR / VLDL Receptor (rh VLDLR / VLDL Receptor; TMPY-01085; NP_003374.3; Met 1-Ser 797). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography. |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | 0.2 μm filtered solution in PBS |
| Research Background | The very low density lipoprotein receptor, known as VLDLR, is a single-pass type 1 integral membrance protein and a member of the LDL receptor family. This receptor family includes LDL receptor, LRP, megalin, VLDLR and ApoER2, and is characterized by a cluster of cysteine-rich class A repeats, epidermal growth factor (EGF)-like repeats, YWTD repeats and an O-linked sugar sdomain. VLDLR contains 3 EGF-like domains, 8 LDL-receptor class A domains, as well as 6 LDL-receptor class B repeats, and is abundant in heart, skeletal muscle, also ovary and kidney, but not in liver. VLDLR binds VLDL and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin-coated pits. VLDLR mediates the phosphorylation of mDab1 (mammalian disabled protein) via binding to Reelin, and induces the modulation of Tau phosphorylation. This pathway regulates the migration of neurons along with the radial glial fiber network during brain development. Defects of VLDLR may be the cause of VLDLR-associated cerebellar hypoplasia (VLDLRCH), a syndrome characterized by moderate-to-profound mental retardation, delayed ambulation, and predominantly truncal ataxia. |
| Conjucates | Unconjugated |
| Immunogen | Recombinant Protein: Human VLDLR / VLDL Receptor protein (TMPY-01085) |
| Antigen Species | Human |
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
| Transport | Shipping with blue ice. |
Calculator
Preview
Related Tags: buy Anti-VLDLR Antibody (3U184) | purchase Anti-VLDLR Antibody (3U184) | Anti-VLDLR Antibody (3U184) cost | order Anti-VLDLR Antibody (3U184)
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.